Cargando…

Adjuvant corticosteroid therapy for critically ill patients with COVID-19

Detalles Bibliográficos
Autores principales:	Lu, Xiaofan, Chen, Taige, Wang, Yang, Wang, Jun, Yan, Fangrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235543/ https://www.ncbi.nlm.nih.gov/pubmed/32430057 http://dx.doi.org/10.1186/s13054-020-02964-w

Ejemplares similares

Classification of COVID-19 in intensive care patients
por: Lu, Xiaofan, et al.
Publicado: (2020)

Continuously available ratio of SpO(2)/FiO(2) serves as a noninvasive prognostic marker for intensive care patients with COVID-19
por: Lu, Xiaofan, et al.
Publicado: (2020)

Lessons from a patient with severe aplastic anemia complicated with COVID-19
por: Wang, Yang, et al.
Publicado: (2021)

Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19
por: Wang, Yang, et al.
Publicado: (2020)

Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study
por: Li, Yiming, et al.
Publicado: (2020)

Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype
por: Chen, Hui, et al.
Publicado: (2021)

Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials
por: Sterne, Jonathan A. C., et al.
Publicado: (2020)

Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia
por: Sakr, Yasser, et al.
Publicado: (2021)

Adjuvant Vitamin C in critically ill patients undergoing renal replacement therapy: What’s the right dose?
por: Marik, Paul E, et al.
Publicado: (2018)

Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit()
por: González-Castro, A., et al.
Publicado: (2022)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Potential benefits of precise corticosteroid therapy for critical COVID-19
por: Chen, Qingquan, et al.
Publicado: (2022)

CJEM journal club: corticosteroids use for critically ill COVID-19 patients
por: Li, Siying S., et al.
Publicado: (2021)

The Impact of Corticosteroids on Secondary Infection and Mortality in Critically Ill COVID-19 Patients
por: Ritter, Lindsay A., et al.
Publicado: (2021)

Clinical phenotypes of critically ill COVID-19 patients
por: Azoulay, Elie, et al.
Publicado: (2020)

Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023)

Extracorporeal endotoxin adsorbent therapy in the critically ill patients with COVID-19 during ECMO
por: Fu, Bao, et al.
Publicado: (2023)

Therapeutic response to corticosteroids in a critically ill patient with COVID-19: A case report
por: Wang, Kaige, et al.
Publicado: (2020)

An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients
por: Wang, Jing-Zhang, et al.
Publicado: (2020)

Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment
por: Lu, Chenyang, et al.
Publicado: (2021)

Different barriers to nutritional therapy among critically-ill patients with COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2021)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Do Systemic Corticosteroids Reduce Mortality in Critically Ill Adult Patients With COVID-19?
por: Yoo, Michael J., et al.
Publicado: (2021)

Serum antibody response in critically ill patients with COVID-19
por: Longchamp, Alban, et al.
Publicado: (2020)

Smoking in critically ill patients with COVID-19: the Australian experience
por: Plummer, Mark P., et al.
Publicado: (2023)

Clinical features of critically ill patients with confirmed COVID-19
por: Chu, Yanan, et al.
Publicado: (2020)

Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
por: Brubaker, Lisa, et al.
Publicado: (2021)

Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19
por: Brubaker, Lisa, et al.
Publicado: (2021)

Advances in antibiotic therapy in the critically ill
por: Jia, Rufu, et al.
Publicado: (2016)

Corticosteroid therapy in COVID-19 patients: Don’t forget venous thromboembolism
por: Roncon, Loris, et al.
Publicado: (2021)

The prognosis and short-term efficacy of corticosteroid therapy for COVID-19 patients
por: Jia, Xinyu, et al.
Publicado: (2021)

Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy
por: Dell'Antonia, Massimo, et al.
Publicado: (2021)

Corticosteroids for critically ill COVID-19 patients with cytokine release syndrome: a limited case series
por: Yang, Stephen Su, et al.
Publicado: (2020)

Variants of concern and clinical outcomes in critically ill COVID-19 patients
Publicado: (2023)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
por: Bradbury, Charlotte A., et al.
Publicado: (2023)

Thromboelastography findings in critically ill COVID-19 patients
por: Salem, Nouran, et al.
Publicado: (2020)

Unrecognized diabetes in critically ill COVID-19 patients
por: Klein, Sebastian J., et al.
Publicado: (2020)

Plasma exchange in critically ill COVID-19 patients
por: Morath, Christian, et al.
Publicado: (2020)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekso56dnuh4hq84mhtqhn2ta19